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Here we present the establishment of an inducible system based on the 28 
dimerizable Cre recombinase (DiCre) for controlled gene expression in the protozoan 29 
parasite Leishmania. Rapamycin-induced DiCre activation promoted efficient flipping 30 
and expression of gene products in a time and dose-dependent manner. The DiCre 31 
flipping activity induced the expression of target genes from both integrated and 32 
episomal contexts broadening the applicability of the system. We validated the 33 
system by inducing the expression of both full length and truncated forms of the 34 
checkpoint protein Rad9, which revealed that the highly divergent C-terminal domain 35 
of Rad9 is necessary for proper subcellular localization. Thus, by establishing the 36 
DiCre-based inducible system we have created and validated a robust new tool for 37 
assessing gene function in Leishmania.38 
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The genus Leishmania encompasses over 20 species, including those that 40 
are the causative agents of devastating human diseases worldwide collectively called 41 
leishmaniasis [1]. The Leishmania genome is organized in directional gene clusters 42 
that may include hundreds of genes from which transcription occurs in a polycistronic 43 
fashion. No canonical RNA Pol II promoters have been identified in this parasite and 44 
gene expression regulation seems to have been devolved to post-transcriptional 45 
processes [2]. The remarkable genome plasticity of Leishmania, which leads to 46 
frequent genome rearrangements, not only impacts gene expression control, but also 47 
hinders the genetic manipulation of the parasite [3,4]. Therefore, a dependable and 48 
robust genetic toolkit is necessary for effective post-genomic functional studies in this 49 
protozoan.  50 
Over the past decades, a collection of genetic manipulation tools for 51 
Leishmania has been introduced. For instance, transient and stable transfection, 52 
gene replacement and disruption, expression vectors and functional 53 
complementation and rescue are well-established and reliable tools [5–7]. More 54 
recently, the introduction of protein stabilization strategies [8,9] a tetracycline-55 
inducible system for protein expression [10], the dimerizable Cre recombinase 56 
(DiCre)-based system for inducible knockouts [11,12] and the establishment of 57 
CRISPR cas9 genome editing [13] has further improved our capacity to address 58 
peculiar aspects of this parasite’s biology. Given the stringent regulation of DiCre 59 
recombinase activity and the variety of strategies for genetic regulation conferred by 60 
the use of loxP recombination sites [14,15], we decided to adapt the DiCre-based 61 
inducible system for controlled gene expression in Leishmania major. Our strategy 62 
involves the generation of a cell line constitutively expressing DiCre recombinase and 63 
carrying an inverted gene of interest flanked by cis orientated loxP sites. These 64 
constructs are integrated into the 18S rRNA locus and expressed under the control of 65 
the Pol I promoter. The antisense orientation of the gene of interest prevents 66 
transcription of coding RNA from the positive strand until activation of DiCre 67 
recombinase activity by rapamycin treatment. Once activated, DiCre catalyzes the 68 
‘flip’ of the sequence flanked by cis loxP sites, resulting in transcription of a coding 69 
RNA and subsequent protein expression (Figure S1A). To prevent continual gene 70 
‘flipping’ by loxP site recombination we employed left-element mutant (lox66) and 71 
right-element mutant (lox77) sites [16]. These mutated lox sequences act as sites of 72 
recombination to generate a wild-type loxP site and a double mutant Lox72 site for 73 
which DiCre has a dramatically reduced affinity. As such, a single recombination 74 
3
event is favoured upon DiCre recombinase induction, thereby preventing re-75 
inversion, leading to continual expression of the gene of interest (Figure S1B).  76 
The advantages of this approach include: (i) the use of fewer transfection 77 
rounds and, consequently, fewer selectable markers when compared to the 78 
tetracycline-inducible system developed for L. mexicana by Kraeva and colleagues 79 
[10]; (ii) the possibility to induce expression of gene products from both chromosomal 80 
and/or episomal contexts; (iii) the system promotes a non-leaky expression that can 81 
be induced in a time and dosage-dependent manner; (iv) the possibility to compare 82 
the expression of endogenous and mutated proteins including the conditional 83 
expression of deleterious gene products. 84 
To create the system, plasmid pGL2339 (Figure S2A) was digested and the 85 
array encoding the blasticidin resistance cassette and the dimerizable Cre 86 
recombinase subunits was integrated into the ribosomal locus to generate the 87 
DiCreSSU cell line (Figures 1A and Table S2). Next, the plasmid pGL2332 (Figure 88 
S2B) was digested and the lox66/lox77-flanked 6xHA-GFP cassette containing the 89 
puromycin resistance marker was integrated into the ribosomal locus of the DiCreSSU90 
cell line to generate the GFPflox cell line (Figures 1B and Table S2). Both integration 91 
events were confirmed by PCR analysis, which also ascertained that the 6xHA-GFP 92 
coding sequence was present in the antisense orientation in the GFPflox cell line 93 
(Figure 1C). To test the system and the DiCre flipping activity, the GFPflox cell line 94 
was incubated with the DiCre dimerization ligand, rapamycin, and the inversion of the 95 
GFP cassette was confirmed by PCR analysis using the appropriate set of primers 96 
(Figure 1D). Semi-quantitative PCR analysis showed that the flipping reaction is time 97 
dependent and seem to reach its maximal level around 96 hours after induction 98 
(Figure S3). Importantly, flipping of the GFP cassette in the absence of rapamycin 99 
was not detectable in the PCR analyses shown in Figure 1D or Figure S3, indicating 100 
a non-leaky DiCre activity in the GFPflox cells. Upon rapamycin induction, expression 101 
of 6xHA-GFP was detectable after 12 hours and its levels were dose and time-102 
dependent (Figure 1E). Consistently, 6xHA-GFP was not detectable in the absence 103 
of rapamycin, further confirming the stringent regulation of the system (Figure 1E). 104 
We further used immunofluorescence analysis (IFA) to examine the expression 105 
profile within the population and observed that 6xHA-GFP was detectable by IFA only 106 
after rapamycin incubation (Figure 1F). Consistent with the western blot analysis, the 107 
IFA also demonstrated the rapamycin dose-dependence of the system (Figure S3) 108 
further confirmed by the quantification of GFP corresponding signal (Figure 1G). 109 
Besides confirming the tight regulation of the system, this set of data also 110 
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demonstrates that the system is suitable for subcellular compartmentalization studies 111 
in this parasite.  112 
To expand the limits of the system we tested it for the ability to flip sequences 113 
from an episome, which can be found in multiple copies in the cell. To that end, the 114 
plasmid pGL2332 was transfected into the DiCreSSU cell line to generate the pGFPflox115 
cell line (Figure 1H). PCR analysis confirmed the DiCre background and the 116 
presence of the target plasmid (Figure 1I), and the flipping of the 6xHA-GFP cassette 117 
upon rapamycin incubation (Figure 1J). Consistently, western blot analysis confirmed 118 
the expression of the cassette exclusively in rapamycin treated cells (Figure 1K). 119 
These results further demonstrate the tight control of DiCre activity and greatly 120 
extend the applicability of the system as a reliable tool for inducible protein 121 
expression not only from the genomic context, but also from episomal targets. It is 122 
noteworthy that this system it is not expected to be reversible, which can be a 123 
disadvantage if reversion of the expressed phenotype is required. However, the 124 
irreversibility of the system can be taken an advantageous feature to be explored in 125 
both in vitro and in vivo infections assays where inclusion of selection drugs and 126 
rapamycin might not be desired.  127 
To further validate the DiCre flipping tool we used the protein Rad9, which 128 
participates in the Leishmania DNA Damage Response as part of the checkpoint 129 
clamp 9-1-1 [17,18]. In eukaryotic cells, Rad9 has an unstructured C-terminal domain 130 
that corresponds to ~1/3 of the protein and is necessary for its function in signalling 131 
genotoxic stress [19]. The unstructured C-domain of Leishmania Rad9 is ~3.5x 132 
longer than its human counterpart (Figure 2A) and, so far, no function has been 133 
reported for this C-terminal extension. To start exploring the function of this C-134 
terminal domain, Rad9 full length or C-terminal truncated encoding sequences, were 135 
cloned into the pGL6000 vector (Figure S2C), to generate the Rad9-6xHAflox and 136 
Rad9∆C’-6xHAflox cassettes, respectively. These constructs were digested and 137 
integrated into the ribosomal locus of the DiCreSSU cell line to generate the Rad9flox138 
and Rad9∆C’flox cell lines, respectively (Figure 2B and Table S2). Proper Integration 139 
was confirmed by PCR analysis (Figure 2C) and, as expected, flipping of the 140 
cassettes was detected exclusively upon rapamycin incubation (Figure 2D). 141 
Accordingly, expression of Rad9-6xHA and Rad9∆C’-6xHA was detectable at 142 
comparable levels after induction with rapamycin, as demonstrated by western blot 143 
analysis (Figure 2E; upper panel). Anti-Rad9 polyclonal serum was used in western 144 
blot analysis to evaluate changes in total Rad9 levels (i.e. Rad9-6xHA plus 145 
endogenous Rad9) in the Rad9flox cell line after DiCre activation (Figure 2E; middle 146 
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panel). Our analysis indicated that, upon induction, Rad9-6xHA was overexpressed 147 
when compared to the endogenous Rad9. Quantification of Rad9 signal revealed that 148 
up to ~65% of the total Rad9 expressed in these cells corresponded to the induced 149 
version of the protein demonstrating that the system can mediate overexpression. 150 
Interestingly, the induction of Rad9-6xHA resulted in significant decrease in the levels 151 
of endogenous Rad9. However, the same effect was less pronounced when the 152 
truncated Rad9∆C’-6xHA was expressed (Figure 2E; middle panel and Figure 2F). 153 
These data suggest that Leishmania Rad9 levels are under tight regulation, which 154 
probably involves the participation of its C-terminal extension. Whether this requires 155 
a direct or indirect role of this domain remains to be investigated. We were not able 156 
to properly assess Rad9∆C’-6xHA levels relative to endogenous Rad9 using the 157 
polyclonal anti-Rad9 serum. One reason for this is that anti-Rad9 serum detects a 158 
faster migrating protein with the same molecular mass as Rad9∆C’-6xHA, hindering 159 
its detection. Similarly to the endogenous Rad9, the level of this protein was also 160 
reduced upon induction of Rad9-6xHA (Figure 2E; middle panel). While the presence 161 
of this band could represent cross-detection of an unrelated protein, these data 162 
suggest that it could be a processed form of Rad9 and further characterization is 163 
needed to clarify this.  164 
We also analysed the effect of the deletion of the C-terminal extension on the 165 
Rad9 subcellular localization. Using IFA, we observed that in the majority of the cells 166 
Rad9-6xHA was almost exclusively found in the nuclear compartment, as previously 167 
described for Rad9 [17] (Figures 2G and S4). On the other hand, truncated Rad9∆C’-168 
6xHA presented a less defined localization being prominently detected in the 169 
cytoplasm of the majority of the cells (Figure 2G and S4). Consistently, quantitative 170 
analysis of the IFA data showed that Rad9-6xHA signal is concentrated in the region 171 
containing the nuclear DNA staining, while Rad9∆C’-6xHA signal expands beyond 172 
the nuclear staining limits (Figure 2H). Based on these data, it is reasonable to 173 
conclude that the C-terminal extension is necessary for proper subcellular distribution 174 
of Rad9 in Leishmania.   175 
In summary, we have demonstrated that the DiCre-based expression system 176 
described here is a valuable addition to the Leishmania genetic manipulation toolkit. 177 
Its use to study the parasite Rad9 revealed important features of the protein, 178 
produced reagents for future studies and proved its value for functional analyses in 179 
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Legends to Figures 266 
267 
Figure 1. Establishment of an inducible DiCre-based expression system in L. 268 
major. (A) Schematic representation (not in scale) of the cassette encoding the 269 
truncated forms of DiCre after integration into the 18S ribosomal RNA locus (SSU) of 270 
L. major wild type cell (LT252) to generate the DiCreSSU cell line; BLA: blasticidin 271 
resistance marker. (B) Schematic representation (not in scale) of the 6xHA-GFP 272 
cassette (see Figure S1B for details) after integration into the SSU locus of the 273 
DiCreSSU cell line (A) to generate the GFPflox cell line; PAC: puromycin resistance 274 
marker; upon rapamycin (RAP) addition, the indicated lox sites mediate the flipping of 275 
6xHA-GFP cassette allowing its expression. In (A) and (B), black arrows indicate 276 
approximate annealing position of primers used for PCR analysis. (C) PCR analysis 277 
of genomic DNA (gDNA) using the indicated set of primers (annealing positions 278 
shown in (A) and (B)); DHFR-TS was the loading control for all PCR analyses 279 
presented in this work. (D) PCR analysis of gDNA from GFPflox cells cultivated in the 280 
presence (+) or absence (-) of 100nM RAP for 48h; primers are indicated below each 281 
panel (see annealing positions in (B)). (E) Western blot analysis of total cell extracts 282 
from the GFPflox cells cultivated with RAP for the indicated periods of time; two 283 
distinct cell-equivalent amount of extracts was analysed; anti-HA was used to detect 284 
6xHA-GFP; EF1α was the loading control. (F) Immunofluorescence analysis of 285 
GFPflox cells cultivated in the presence (+) or absence (-) of 100nM RAP for 48h; 286 
images were acquired with a DMI 6000B inverted microscope (Leica); n and k 287 
indicate nuclear and kinetoplast DNA, respectively; scale bar = 5µm. (G) GFPflox cells 288 
were subject to immunofluorescence as in (F) after cultivation with RAP for 48h; 289 
signal corresponding to 6xHA-GFP from individual cells was quantified using Image J 290 
software; bars indicate mean +/- Standard Deviation (S.D.); p values by Kruskal-291 
Wallis test were: (**) = 0.0057; (***) = 0.0008. (H) The plasmid pGL2332 (Figure 292 
S1B) was transfected as a circular episome in the DiCreSSU cells to generate the 293 
pGFPflox cell line; as in (B), RAP addition is expected to induce expression of 6xHA-294 
GFP; schematic representations are not in scale. (I) PCR analysis of gDNA using the 295 
indicated set of primers (annealing positions shown in (A) and (H). (J) PCR analysis 296 
of gDNA from pGFPflox cells cultivated in the presence (+) or absence (-) of 100nM 297 
RAP for 48h; primers are indicated below each panel (see annealing position in (H)).298 
(K) Western blot analysis of total cell extracts from the pGFPflox cells cultivated in the 299 
presence (+) or absence (-) of 100nM RAP for 48h; anti-HA was used to detect 300 
6xHA-GFP; EF1α was the loading control. 301 
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Figure 2. Expression of Rad9 and Rad9∆C’ using the DiCre-based inducible 303 
system. (A) Predicted amino acid sequence of Rad9 from L. major (LmjF.15.0980) 304 
and Homo sapiens (NP_004575.1) were subject to disorder prediction using IUPred 305 
(http://iupred.enzim.hu); values above 0.5 (horizontal black dotted line) can be 306 
considered as disordered regions; horizontal grey bars above each graph indicate 307 
the Rad9 domain (Pfam: PF04139) and the disordered C-terminal domain; C-terminal 308 
domain of human Rad9 and the corresponding region in L. major Rad9 is indicated 309 
as C; the extended C-terminal of L. major Rad9 is indicated as C’. (B) Full length 310 
Rad9 from L. major or a truncated version lacking the C-terminal extension (C’), were 311 
cloned as C-terminal fusion with a 6xHA tag to generated the Rad9-6xHAflox and 312 
Rad9∆C’-6xHAflox constructs (not in scale); Rad9-6xHA and Rad9∆C’-6xHA 313 
constructs are arranged in an inverted orientation, flanked by the indicated lox 314 
sequences and were integrated into the ribosomal locus (SSU) of the DiCreSSU cells 315 
(see Figure 1A) to generate the Rad9flox and Rad9∆C’flox cell lines, respectively; black 316 
arrows indicate approximate annealing position of oligonucleotides used for PCR 317 
analyses; PAC: puromycin resistance marker. (C) PCR analysis of gDNA using the 318 
indicated set of primers (see annealing positions in (B)). (D) PCR analysis of gDNA 319 
from cells cultivated in the presence (+) or absence (-) of 100nM RAP for 48h; 320 
primers are indicated below each panel (see annealing positions in (B)). (E)321 
Western blot analysis of total cell extracts from the indicated cells cultivated in the 322 
presence (+) or absence (-) of RAP for 48 hours; anti-HA (upper panel) and anti-323 
Rad9 (bottom panel) was used to detect Rad9-6xHA Rad9∆C’-6xHA; a protein with a 324 
similar migration pattern of Rad9∆C’-6xHA is detected by anti-Rad9 and is indicated 325 
with (*); GAPDH was the loading control. (F) Levels of endogenous Rad9 in western 326 
blot analysis shown in (E) were determined and normalized with the GAPDH signal, 327 
using Image J software; signal from cells exposed to RAP was plotted as a fraction 328 
relative to signal from respective non-induced culture. (G) Immunofluorescence 329 
analysis of the indicated cells cultivated in the presence (+) or absence (-) of 100nM 330 
RAP for 48h; images are representative of a Z-maximal projection from 14 Z-slices 331 
acquired with a multiphoton system coupled with LMS780 AxioObserver microscope 332 
(Zeiss); n and k indicate nuclear and kinetoplast DNA, respectively; black bars on the 333 
DIC field indicate the section where quantification shown in (H) was performed; n and 334 
k indicate nuclear and kinetoplast DNA, respectively; scale bar (white) = 5µm. (H) 335 
Signal corresponding to DAPI, Rad9-6xHA and Rad9∆C’-6xHA  in the section 336 
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Figure S1. Schematic description of the flipping activity catalysed by DiCre recombinase. 
(A) DiCre recognizes cis-inverted loxP sites and catalyse the inversion of any flanked sequence; 
the same loxP sequences are generated upon inversion, therefore re-inversion can proceed 
with the same efficiency; loxP sequence (5’ to 3’) is shown in the inset.  
(B) Right and left mutated elements lox66 and lox77, respectively, are used to flank the 
sequence of interest; the sequences (5’ to 3’) for lox66 and lox77 are shown in the insets; red 
lower case indicate the mutated nucleotides; upon inversion, loxP and lox72 sequences are 

















Figure S2. Description of the plasmids and strategies used to generate the cell lines 
reported in this work.  
(A) pGL2339 plasmid bears the cassette encoding the inactive truncated forms of Cre-
recombinase (DiCre) FKBP12-Cre59 and FRB-Cre60; to generate the DiCreSSU cell line; the 
plasmid was digested with PacI and PmeI restriction enzymes and transfected into the L. major 
WT cell line (LT252); cells bearing the integration into the 18S ribosomal locus were cloned by 
serial dilution in M199 medium containing 10µg/ml blasticidin.  
(B) pGL2332 plasmid bears the coding sequence for N-terminal 6xHA-tagged GFP; this fusion 
is inverted in relation to the 5’ and 3’ SSU sequences, and flanked by lox66 and lox77 sites; to 
generate the GFPflox cell line, pGL2332 was digested with PacI and PmeI restriction enzymes 
and transfected into the DiCreSSU cell line; cells bearing the integration into the 18S ribosomal 
locus were cloned by serial dilution in M199 medium containing 10µg/ml  puromycin and 10µg/
ml blasticidin.  
(C) To generate pGL6000 plasmid, pGL2332 was digested with KpnI and NheI restriction 
enzymes to remove the 6xHA-GFP coding sequence and ligated to a PCR product bearing the 
6xHA tag and a multiple cloning site containing SdaI, NdeI and BglII restriction sites; the 
resulting vector allows for cloning of genes of interest as a C-terminal 6xHA fusion flanked by 
the lox66/lox77 sites; to generate the pGL6002 and pGL6004 plasmids, PCR products of the 
coding sequence for the full length or C-terminal truncated Rad9, respectively, were cloned into 
SdaI and NdeI restriction sites of the pGL6000 plasmid; to generate the Rad9flox and Rad9ΔC’flox 
cell lines, pGL6002 and pGL6004 plasmids, respectively, were digested with PacI and PmeI 
restriction enzymes and transfected into the DiCreSSU cell line; selection and cloning of 
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Figure S3. Time course analysis of DiCre-mediated flipping efficiency.  
(A) Schematic representation (not in scale) of the 6xHA-GFP cassette after integration into the 
SSU locus of the DiCreSSU cell line to generate the GFPflox cell line; PAC: puromycin resistance 
marker; upon rapamycin (RAP) addition, the indicated lox sites mediate the flipping of 6xHA-
GFP cassette allowing its expression; a, c, d and e indicate approximate annealing position of 
oligonucleotides used for the PCR analyses shown in (B).  
(B) Genomic DNA (gDNA) was extracted from GFPflox cell line after cultivation with 100nM RAP 
for the indicated period of time; ~ 10ng of gDNA was subjected to semi-quantitative PCR 
analysis using the indicated set of primers; ~15% of the PCR reaction was resolved in agarose 
gels; the number of cycles performed in each PCR reaction is indicated at right; annealing 
position for primers c+d and a+e, which detect only the molecules that has not been flipped, is 
shown in (A); DHFR-TS was used as the loading control.  
(C) Signal corresponding to PCR products using primers c+d and a+e shown in (A) was 
measured using Image J software and then normalized with DHFR-TS signal; mean values 
obtained with each set of primers were calculated for each time point and are expressed relative 
to the 0 hours time point; vertical lines indicate standard error of the mean. 
Figure S4	
Figure S4. GFPflox cell line was cultivated in the presence of the indicated rapamycin 
concentrations for 48 hours; cells were fixed and subjected to immunofluorescence 
analysis using mouse anti-HA as primary antibody and anti-mouse conjugated with 
Alexa-Fluor 488 as secondary antibody (false coloured green); images were acquired 


























Figure S5. Rad9flox and Rad9ΔC’flox cell lines were cultivated in the presence (+) or 
absence (-) of rapamycin for 48 hours; cells were fixed and subjected to 
immunofluorescence analysis using mouse anti-HA as primary antibody and anti-mouse 
conjugated with Alexa-Fluor 488 as secondary antibody; images were acquired as a 
series of 14 Z-slices with a multiphoton system coupled with LMS780 AxioObserver 
microscope (Zeiss); images are representative of a Z-maximal projection from 14 Z-










































Suplementary Table 1: Primers used in this work 
Designation in text Sequence (5’→3’) Reference  
a  CATTCCGTGCGAAAGCCGG Duncan et al., 2016 
b  GATGGTTTCCACCTGCAC 
c  CCGTGGGCTTGTACTCGGTCA 
d  CTCGCCCTTGCTCACCAT This work 
e  GGCATGGACGAGCTGTACAAG 
f ATTCTCGAGATGTCACTCCAATTCACAGTGAG (XhoI Site) 
Rad9NdeIFw  ATTCATATGATGTCACTCCAATTCACAGTGAG (NdeI site) 
Rad9ABCSdaIRv ATTCCTGCAGGGTTCTGCGTCGGCCCTCGCGACAT (SdaI site) 





Suplementary Table 2: Cell lines used in this work 
Designation in text Genetic nomenclature 
DiCreSSU SSU DiCre BLA 
GFPflox SSU DiCre BLA SSU lox66((6xHA::GFP)AS)lox77
 PAC 
pGFPflox SSU DiCre BLA [lox66((6xHA::GFP)AS)lox77 PAC] 
Rad9flox SSU DiCre BLA SSU lox66((Rad9::6xHA)AS)lox77
 PAC 
Rad9ΔC’flox SSU DiCre BLA SSU lox66((Rad9ΔC::6xHA)AS)lox77
 PAC 





L. major LT252 (MHOM/IR/1983/IR) and all other cell lines were cultured as promastigotes at 
26°C in M199 medium plus 10% heat-inactivated fetal bovine serum. Generation of cell lines 
was done using the transfection protocol previously described (Kapler et al., 1990).   
 
 
PCRs and cloning 
Genomic DNA was extracted with DNeasy Blood & Tissue Kit (QIAGEN) according to 
manufacturer instructions. PCRs were performed using Taq DNA Polymerase (Thermo) for 
products up to 2kb or Phusion® High-Fidelity DNA Polymerase (NEB) for products with more 
than 2kb.  
For generation of pGL6002 plasmid, the sequence coding for the 718 amino acids of full length 
Rad9 was amplified from gDNA using Rad9NdeIFw and Rad9ABCSdaIRv as primers (Table 
S1). For generation of pGL6004 plasmid, the sequence coding for the first 370 amino acids of 
Rad9 was amplified from gDNA using Rad9NdeIFw and Rad9ABSdaIRv as primers (Table S1).  
 
 
Antibodies and western blotting analyses 
Rabbit anti-LmRad9 antibody was previously described (Damasceno et al., 2013) and was used 
at 1:3 000 dilution. Rabbit anti-GAPDH antibody was kindly provided by Dr. Paul Michels and 
was used at the 1:15 000 dilution. The commercial antibodies used were as follows: mouse anti-
HA (Sigma-Aldrich) at 1:1000 dilution, mouse anti-EF1α (Merck Millipore) at 1:50 000 dilution. 
HRP-conjugated anti-mouse and anti-Rabbit antibodies (GE Life Sciences) were used at 1:10 
000 and 1: 30 000 dilution, respectively.  
 
Unless otherwise indicated, total cell extracts equivalent to ~106 cells were resolved by SDS-
PAGE, transferred to PVDF membrane (GE Life Sciences) and analyzed with the indicated 
antibodies. Bands were detected with ECL Prime Western Blotting Detection Reagent (GE Life 




Cells were fixed with 4% paraformaldehyde for 10 min at room temperature. Fixed cells were 
adhered to poly-L-lysine coated glass slides and permeabilized with 0.3% Triton X-100 for 30 
min. Cells were pre-blocked with 2% BSA in 1x PBS for 1 hour. Anti-HA antibody was used at 
1:1000 dilution to detect 6xHA-GFP, Rad9-6xHA and Rad9ΔC-6xHA. Primary antibody was 
visualized with anti-mouse secondary antibody conjugated with Alexa Fluor 488 or Alexa Fluor 
594 (Invitrogen). Slides were mounted with ProLong® Gold Antifade Reagent (Thermo) and 2µg/





















































































ORI   7197 - 7870 
5’SSU   108 - 361 
FKBP12   624 - 935   
Cre59   981 - 1106 
FRB   2178 - 2454 
Cre60   2490 - 3344 
BLA   3864 - 4259 
3’SSU   4603 - 5558 


























































































5’SSU   409 - 662 
pXSL   663 - 850 
Lox66   860 - 893 
GFP   1652 – 936 C 
6xHA   1841 – 1677 C 
Lox77   1884 – 1851 C 
PAS   2876 
PAC   3578 - 4174 
3’SSU   5518 - 6477 
ORI   7462 – 6723 C  






















































































5’SSU   409 - 662 
pXSL   663 - 850 
Lox66   860 - 893 
6xHA   1152 – 946 C  
Lox77   1238 – 1205 C 
PAS   2230 
PAC   2932 - 3528 
3’SSU   4872 - 5831 
ORI   6816 – 6077 C 
AMP   7879 – 7019 C 
